Feedback / Questions
Hiltonol (poly-ICLC) - Oncovir
Mobista (CDX-301) - Celldex
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT03789097
May 23, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next